Factors Associated With Breast Cancer Risks and Outcomes

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

750 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-12-08

Study Completion Date

2031-12-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to learn more about risks and outcomes of breast cancer in people with different backgrounds. Tissue and blood will be collected from participants for research purposes. Participants will complete questionnaires during their standard medical care. The study will not provide treatment for cancer or any other condition.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Breast cancer Memorial Sloan Kettering Cancer Center 25-335

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Participants with a suspicious breast finding or new breast cancer diagnosis

Participants with a suspicious breast finding who present to breast radiology at MSK for biopsy or a participants with a new breast cancer diagnosis who is a surgical candidate seen at MSK.

Survey

Intervention Type OTHER

Complete surveys:

* Baseline (within 6 months of enrollment)
* 1st follow-up survey (approx. 6 months to 12 months)
* 2nd follow-up survey and/or blood collection (approx. 3 years +/- 6 months)
* 3rd follow-up survey and/or blood collection (approx. 5 years +/- 6 months)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Survey

Complete surveys:

* Baseline (within 6 months of enrollment)
* 1st follow-up survey (approx. 6 months to 12 months)
* 2nd follow-up survey and/or blood collection (approx. 3 years +/- 6 months)
* 3rd follow-up survey and/or blood collection (approx. 5 years +/- 6 months)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

A patient cannot be considered eligible for this study unless the following conditions are met.

* Patients with a suspicious breast finding who present to breast radiology at MSK for biopsy or any new breast cancer patient who is a surgical candidate seen at MSK.
* Women 18 years of age and older are eligible to participate in the study.

Exclusion Criteria

* Patients presenting to radiology for biopsy with a suspicious breast mass less than 1 cm will be considered ineligible.
* Patients presenting to clinic with microinvasion will be considered ineligible.
* Patients who are less than 18 years of age will be considered ineligible.
* Patients unable to complete the survey, including IDMC patients.

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Neha Goel, MD, MPH

Role: PRINCIPAL_INVESTIGATOR

Memorial Sloan Kettering Cancer Center

Review the countries where the study has at least one active or historical site.

Factors Associated With Breast Cancer Risks and Outcomes

Study Results

Basic Information

Brief Summary

Detailed Description

Conditions

Keywords

Study Design

Study Groups

Participants with a suspicious breast finding or new breast cancer diagnosis

Survey

Interventions

Survey

Eligibility Criteria

Inclusion Criteria

Exclusion Criteria

Sponsors

Memorial Sloan Kettering Cancer Center

Responsible Party

Principal Investigators

Neha Goel, MD, MPH

Locations

Memorial Sloan Kettering Cancer Center Basking Ridge (Limited Protocol Activities)

Memorial Sloan Kettering Monmouth (Limited Protocol Activities)

Memorial Sloan Kettering Bergen (Limited Protocol Activities)

Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities)

Memorial Sloan Kettering Westchester (Limited Protocol Activities)

Memorial Sloan Kettering Cancer Center (All Protocol Activites)

Memorial Sloan Kettering Nassau (Limited Protocol Activites)

Countries

Central Contacts

Neha Goel, MD, MPH

George Plitas, MD

Facility Contacts

Neha Goel, MD, MPH

Neha Goel, MD, MPH

Neha Goel, MD, MPH

Neha Goel, MD, MPH

Neha Goel, MD, MPH

Neha Goel, MD, MPH

Neha Goel, MD, MPH

Related Links

Other Identifiers

25-335